A detailed history of Enterprise Financial Services Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Enterprise Financial Services Corp holds 1,751 shares of LLY stock, worth $1.31 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares
1,751
Previous 1,778 1.52%
Holding current value
$1.31 Million
Previous $1.61 Million 3.6%
% of portfolio
0.91%
Previous 1.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$772.14 - $960.02 $20,847 - $25,920
-27 Reduced 1.52%
1,751 $1.55 Million
Q2 2024

Aug 13, 2024

SELL
$724.87 - $909.04 $7,248 - $9,090
-10 Reduced 0.56%
1,778 $1.61 Million
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $53,890 - $72,097
-91 Reduced 4.84%
1,788 $1.39 Million
Q4 2023

Feb 09, 2024

BUY
$525.19 - $619.13 $21,532 - $25,384
41 Added 2.23%
1,879 $1.1 Million
Q3 2023

Oct 31, 2023

SELL
$434.7 - $599.3 $6,520 - $8,989
-15 Reduced 0.81%
1,838 $987,000
Q2 2023

Aug 11, 2023

BUY
$350.74 - $468.98 $4,208 - $5,627
12 Added 0.65%
1,853 $869,000
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $15,220 - $17,876
-49 Reduced 2.59%
1,841 $632,000
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $13,826 - $16,110
43 Added 2.33%
1,890 $691,000
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $4,447 - $5,068
15 Added 0.82%
1,847 $597,000
Q2 2022

Aug 09, 2022

BUY
$278.73 - $327.27 $3,344 - $3,927
12 Added 0.66%
1,832 $594,000
Q1 2022

May 16, 2022

BUY
$234.69 - $291.66 $18,540 - $23,041
79 Added 4.54%
1,820 $521,000
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $7,420 - $9,208
33 Added 1.93%
1,741 $481,000
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $30,580 - $37,633
138 Added 8.79%
1,708 $395,000
Q2 2021

Aug 16, 2021

SELL
$180.55 - $233.54 $18,055 - $23,354
-100 Reduced 5.99%
1,570 $360,000
Q1 2021

May 13, 2021

BUY
$164.32 - $212.72 $23,333 - $30,206
142 Added 9.29%
1,670 $312,000
Q4 2020

Feb 12, 2021

SELL
$130.46 - $172.63 $128,503 - $170,040
-985 Reduced 39.2%
1,528 $258,000
Q3 2020

Nov 13, 2020

SELL
$146.22 - $169.13 $1,315 - $1,522
-9 Reduced 0.36%
2,513 $372,000
Q2 2020

Aug 04, 2020

BUY
$136.42 - $164.18 $8,321 - $10,014
61 Added 2.48%
2,522 $414,000
Q1 2020

May 15, 2020

SELL
$119.05 - $147.35 $3,333 - $4,125
-28 Reduced 1.12%
2,461 $342,000
Q4 2019

Jan 28, 2020

SELL
$106.92 - $132.43 $3,100 - $3,840
-29 Reduced 1.15%
2,489 $328,000
Q3 2019

Oct 31, 2019

BUY
$106.79 - $116.16 $3,524 - $3,833
33 Added 1.33%
2,518 $282,000
Q2 2019

Jul 30, 2019

BUY
$110.79 - $129.32 $332 - $387
3 Added 0.12%
2,485 $275,000
Q1 2019

Apr 26, 2019

BUY
$111.31 - $131.02 $107,636 - $126,696
967 Added 63.83%
2,482 $322,000
Q4 2018

Jan 25, 2019

SELL
$105.9 - $118.64 $4,765 - $5,338
-45 Reduced 2.88%
1,515 $175,000
Q3 2018

Oct 26, 2018

BUY
$85.86 - $107.31 $6,697 - $8,370
78 Added 5.26%
1,560 $167,000
Q2 2018

Jul 27, 2018

BUY
$75.7 - $86.88 $3,330 - $3,822
44 Added 3.06%
1,482 $126,000
Q1 2018

Apr 27, 2018

SELL
$74.21 - $87.6 $148 - $175
-2 Reduced 0.14%
1,438 $111,000
Q4 2017

Jan 26, 2018

SELL
$81.94 - $87.89 $2,212 - $2,373
-27 Reduced 1.84%
1,440 $122,000
Q3 2017

Oct 27, 2017

BUY
$77.07 - $85.54 $113,061 - $125,487
1,467
1,467 $125,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Enterprise Financial Services Corp Portfolio

Follow Enterprise Financial Services Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

News

Stay updated on Enterprise Financial Services Corp with notifications on news.